Watch this 3 min video to hear from the CEO & President of Kiara Health (Pty) Ltd, explains how SAP’s S/4HANA now forms a solid foundation…
The LightStrike Robot is supported by extensive laboratory and environmental research published in peer-reviewed journals and by microbiology testing…
VORTRAN Medical recently had the privilege to participate in a Case Study from which a working protocol was created, based on a hospital’s use of the GO2VENT…
Due to the limitations of its existing legacy monitoring and control infrastructure as a result of the incorporation of the Kiara Health business into the acquired manufacturing arm…
The arrival of several vaccines against the SARS-CoV-2 virus is a global and scientific feat to be commended.
Exxaro Resources awarded Kiara Health for its acquisition of the Novartis / Sandoz manufacturing operations. Skhumbuzo Ngozwana , CEO and President of Kiara Health accepted the award
Kiara acquired the internationally GMP compliant Novartis plant, and twenty-six marketing authorisations (MAs) from Novartis’ subsidiary generic drugs manufacturer, Sandoz South Africa, contract manufacturing selected products for Sandoz SA for a four-year period.
Kiara Health is officially the first and only customer on the African continent with a fully scaled server deployed in the AWS Cloud.
Kiara Health (Pty) Ltd is proud to have been chosen as the partner, in select SSA markets, to Shin Poong Pharmaceutical Co. Ltd., South Korea, for the marketing and distribution of their WHO prequalified artesunate-pyronaridine (AS-PY) fixed-dose antimalarial combination, co-developed with Medicines for Malaria Venture (MMV).